Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
Collignon A, Hospital MA, Montersino C, Courtier F, Charbonnier A, Saillard C, D'Incan E, Mohty B, Guille A, Adelaïde J, Carbuccia N, Garnier S, Mozziconacci MJ, Zemmour C, Pakradouni J, Restouin A, Castellano R, Chaffanet M, Birnbaum D, Collette Y, Vey N. Collignon A, et al. Among authors: carbuccia n. Blood Cancer J. 2020 Jun 3;10(6):64. doi: 10.1038/s41408-020-0330-5. Blood Cancer J. 2020. PMID: 32488055 Free PMC article. Clinical Trial.
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
Collette Y, Prébet T, Goubard A, Adélaïde J, Castellano R, Carbuccia N, Garnier S, Guille A, Arnoulet C, Charbonier A, Mozziconacci MJ, Birnbaum D, Chaffanet M, Vey N. Collette Y, et al. Among authors: carbuccia n. Blood Cancer J. 2015 Mar 13;5(3):e292. doi: 10.1038/bcj.2015.13. Blood Cancer J. 2015. PMID: 25768406 Free PMC article. No abstract available.
Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia.
Murati A, Adélaïde J, Mozziconacci MJ, Popovici C, Carbuccia N, Letessier A, Birg F, Birnbaum D, Chaffanet M. Murati A, et al. Among authors: carbuccia n. Br J Haematol. 2004 Jun;125(5):601-4. doi: 10.1111/j.1365-2141.2004.04960.x. Br J Haematol. 2004. PMID: 15147375 Free article.
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
Rocquain J, Carbuccia N, Trouplin V, Raynaud S, Murati A, Nezri M, Tadrist Z, Olschwang S, Vey N, Birnbaum D, Gelsi-Boyer V, Mozziconacci MJ. Rocquain J, et al. Among authors: carbuccia n. BMC Cancer. 2010 Aug 2;10:401. doi: 10.1186/1471-2407-10-401. BMC Cancer. 2010. PMID: 20678218 Free PMC article.
Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F, Finetti P, Guille A, Adélaïde J, Garnier S, Carbuccia N, Monneur A, Charafe-Jauffret E, Goncalves A, Viens P, Birnbaum D, Chaffanet M. Bertucci F, et al. Among authors: carbuccia n. Oncotarget. 2016 May 10;7(19):27208-19. doi: 10.18632/oncotarget.8349. Oncotarget. 2016. PMID: 27028851 Free PMC article.
Epigenetically centered evolution in an example of myeloid malignancy.
Adélaide J, Cervera N, Carbuccia N, Garnier S, Guille A, Mozziconnaci MJ, Devillier R, Chaffanet M, Vey N, Birnbaum D, Gelsi-Boyer V. Adélaide J, et al. Among authors: carbuccia n. Am J Hematol. 2016 Sep;91(9):E361-2. doi: 10.1002/ajh.24450. Epub 2016 Jul 4. Am J Hematol. 2016. PMID: 27299509 Free article. No abstract available.
Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.
Courtier F, Carbuccia N, Garnier S, Guille A, Adélaïde J, Cervera N, Gelsi-Boyer V, Mozziconacci MJ, Rey J, Vey N, Chaffanet M, Birnbaum D, Murati A. Courtier F, et al. Among authors: carbuccia n. Haematologica. 2017 Jan;102(1):e11-e14. doi: 10.3324/haematol.2016.152363. Epub 2016 Oct 14. Haematologica. 2017. PMID: 27742771 Free PMC article. No abstract available.
56 results